Skip to main content

Pain Catastrophizing

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Cognitive behavioral therapyN/A1 trial
Active Trials
NCT02640079Completed24Est. Nov 2017
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Empowered ReliefN/A1 trial
Active Trials
NCT06443164Enrolling By Invitation78Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsEmpowered Relief
Angeles TherapeuticsCognitive behavioral therapy

Clinical Trials (2)

Total enrollment: 102 patients across 2 trials

Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery

Start: May 2024Est. completion: Dec 202578 patients
N/AEnrolling By Invitation
NCT02640079Angeles TherapeuticsCognitive behavioral therapy

A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea

Start: Jan 2016Est. completion: Nov 201724 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.